Literature DB >> 10472415

Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia.

D A Lewis1, J N Pierri, D W Volk, D S Melchitzky, T U Woo.   

Abstract

Dysfunction of the dorsolateral prefrontal cortex appears to be a central feature of the pathophysiology of schizophrenia, and this dysfunction may be related to alterations in gamma aminobutyric acid (GABA) neurotransmission. Determining the causes and consequences of altered GABA neurotransmission in schizophrenia, and the relationship of these changes to other abnormalities in prefrontal cortical circuitry, requires an understanding of which of the multiple subpopulations of cortical GABA neurons are affected. The chandelier class of GABA neurons, especially those located in the middle layers of the prefrontal cortex (PFC), have been hypothesized to be preferentially involved in schizophrenia because they 1) receive direct synaptic input from dopamine axons, 2) exert powerful inhibitory control over the excitatory output of layer 3 pyramidal neurons, and 3) undergo substantial developmental changes during late adolescence, the typical age of onset of schizophrenia. Consistent with this hypothesis, the axon terminals of chandelier neurons, as revealed by immunoreactivity for the GABA membrane transporter, are reduced substantially in the middle layers of the PFC in schizophrenic subjects. This alteration appears to be selective for the chandelier class of GABA neurons and for the disease process of schizophrenia. These findings provide insight into the pathophysiologic mechanisms underlying prefrontal cortical dysfunction in schizophrenia, and they reveal new targets for therapeutic intervention in this illness.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10472415     DOI: 10.1016/s0006-3223(99)00061-x

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  62 in total

Review 1.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

2.  Synaptic basis of persistent activity in prefrontal cortex in vivo and in organotypic cultures.

Authors:  Jeremy K Seamans; Lourdes Nogueira; Antonieta Lavin
Journal:  Cereb Cortex       Date:  2003-11       Impact factor: 5.357

Review 3.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 4.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

5.  Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.

Authors:  E C Muly; J R Votaw; J Ritchie; L L Howell
Journal:  J Pharmacol Exp Ther       Date:  2012-01-03       Impact factor: 4.030

6.  Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia.

Authors:  R Y Cho; R O Konecky; C S Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-14       Impact factor: 11.205

7.  Gender-specific effect of Mthfr genotype and neonatal vigabatrin interaction on synaptic proteins in mouse cortex.

Authors:  Elinor Blumkin; Tamar Levav-Rabkin; Osnat Melamed; Dalia Galron; Hava M Golan
Journal:  Neuropsychopharmacology       Date:  2011-04-13       Impact factor: 7.853

8.  Increased interstitial white matter neuron density in the dorsolateral prefrontal cortex of people with schizophrenia.

Authors:  Yang Yang; Samantha J Fung; Alice Rothwell; Si Tianmei; Cynthia Shannon Weickert
Journal:  Biol Psychiatry       Date:  2010-10-25       Impact factor: 13.382

9.  Hyperactivity in mice lacking one allele of the glutamic acid decarboxylase 67 gene.

Authors:  Karen Müller Smith
Journal:  Atten Defic Hyperact Disord       Date:  2018-03-19

10.  Convergent Inputs from the Hippocampus and Thalamus to the Nucleus Accumbens Regulate Dopamine Neuron Activity.

Authors:  Stephanie M Perez; Daniel J Lodge
Journal:  J Neurosci       Date:  2018-10-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.